18 January 2024
Seqens and Pleryon Collaborate on GMP Polymer for Osteoarthritis Treatment
Seqens will develop and produce Pleryon's osteoarthritis polymer at its upgraded French facility, enhancing GMP capabilities for medical and pharmaceutical applications.
